Home
Live Updates
Lithuanian biotech secures €4.5 million to advance global commercialization of next-gen single cell analysis technology : comparemela.com
Lithuanian biotech secures €4.5 million to advance global commercialization of next-gen single cell analysis technology
Atrandi Biosciences, a startup based in Vilnius and Denver, has raised €4.5 million in a funding round led by Vsquared Ventures along with participation from
Related Keywords
Denver ,
Colorado ,
United States ,
Lithuania ,
Vilnius ,
Vilniaus Apskritis ,
Lithuanian ,
Donatas Keras ,
Atrandi Biosciences ,
Juozas Nainys ,
Lise Rechsteiner ,
Vsquared Ventures ,
Practica Capital ,
Chief Executive Officer ,
General Partner ,
Droplet Genomics ,
comparemela.com © 2020. All Rights Reserved.